6th In-House Impact: Biopharma Summit 2025
August 27 - 28, 2025 - MA USHanson Wade
info@hansonwade.com
Phone:(+1) 617 455 4188
As the regulatory landscape continues to evolve, 2025 is a pivotal year for legal leaders in biopharma. The 6th In-House Impact: Biopharma Summit is your exclusive opportunity to unite with top legal minds from Takeda, Kura Oncology, Neurocrine Biosciences, and more to tackle today's most pressing challenges-tariffs, financing, M and A strategy, and beyond. Tailored for General Counsels and Chief Legal Officers at drug development companies, this intimate, peer-led summit empowers you to elevate legal as a business-critical function. Learn how in-house teams are adapting to economic volatility, harnessing new legal tech, and navigating cross-functional leadership demands, all while building a valuable network of peers. This is not just another conference. It's a strategic inflection point. Free to attend for biopharma's in-house counsel, this event will help you transition from a traditional lawyer to a corporate leader, ready to drive business success. Time: 9:00 AM - 5:00 PM